Search

You searched for "research"

2268 results found

Small grant award

3 July 2025 | opportunities, news, grants, awards, funding
Fight For Sight/Stargardt's Connected: Short Grant Award Fight for Sight and Stargardt's Connected are pleased to invite calls for early career clinical or research scientists proposing Stargardt’s research projects to collect preliminary or pilot data for developing competitive follow-on funding...

Aniridia Network Conference and Annual General Meeting (AGM) 2023

2 September 2023
@10:00 AM - 5:00PM
Ocular Oncology and Pathology cover image

Quality of life concerns after uveal melanoma diagnosis

5 August 2020 | | EYE - Pathology, EYE - Oncology
The authors sought to investigate factors associated with Quality Of Life (QOL) after initial diagnosis of uveal melanoma (UM) using prospectively collected data between September 2011-May 2016. They included 201 participants referred for radiotherapy after UM diagnosis by an ophthalmic...

Blindness from some inherited eye diseases may be caused by gut bacteria

8 March 2024 | research, UCL, Moorfields, Antimicrobials, Bacteria, study
Sight loss in certain inherited eye diseases may be caused by gut bacteria, and is potentially treatable by antimicrobials, finds a new study in mice co-led by a UCL and Moorfields researcher.

Planes, trams, and auditoriums: Beware predatory conferencing

4 December 2024 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
Predatory open-access journals and predatory conferences are considered the two main areas of predatory infiltration in academic medicine that are of growing concern [1–7]. Unsolicited publishing requests from potentially predatory publishers occur frequently among faculty in ophthalmology [8]. Predatory conferencing...

Inherited retinal disorders now the leading cause of blindness

1 April 2014 | | EYE - Vitreo-Retinal
The recent paper in BMJ Open, from the UCL Institute of Ophthalmology, ‘A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010’ concludes that inherited retinal disorders (IRD) such...

AI predicts eye damage from autoimmune drug, years before symptoms appear

1 September 2025 | artificial intelligence, hydroxychloroquine, pharmacology, research, Moorfields
A novel AI tool could transform screening for patients taking hydroxychloroquine by spotting early signs of eye damage, according to a study published in Opthalmology Retina. Researchers have devised an artificial intelligence (AI) system that can detect and predict serious...

Moorfields Eye Charity appoints Dr Louise Wood CBE as new chair

3 June 2024 | Louise Wood, Moorfields, Industry, infrastructure, charity, hospital, grants, Appointments
Dr Louise Wood CBE has been appointed as Moorfields Eye Charity’s new chair and will succeed Mervyn Walker when he steps down from the role in July 2024.

GREG: An Introduction to Diabetic Retinopathy Grading

4 June 2026 -5 June 2026
Gloucestershire Research & Education Group An Introduction to Diabetic Retinopathy (DR) Grading

Esme’s Umbrella announces the world’s first Charles Bonnet Syndrome Essay Prizes

20 February 2023 |
Esme’s Umbrella (www.charlesbonnetsyndrome) has just announced the world’s first Charles Bonnet Syndrome Essay Prizes.

Beyond vision loss: Why doctors should know about Charles Bonnet Syndrome

19 January 2026 | | EYE - Neuro-ophthalmology, EYE - Vitreo-Retinal
Over 250 years have passed since Charles Bonnet’s seminal essay, in which he described the symptoms of the syndrome that now takes his name [1]. Charles Bonnet Syndrome (CBS) describes the occurrence of visual hallucinations in people with significant visual...

EQUALeyes: Illuminating insights into using health data, AI and inclusion

24 October 2024
Reflecting the Bloomsbury Festival theme of Human.Kind, and current public conversations on the benefits and potential threats of AI, we bring together leaders in the field of healthcare AI to discuss key issues, with a special focus on eyes.